drugset / Trial / NCT00493506
ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency
Non-randomizedParallel-groupOpen-labelSupportive care
Summary
The purpose of this study is to determine the safety and effects in HIV patients of supplementation (4-20 fl. oz. daily) with ProAlgaZyme, a novel fermentation product of a freshwater algae ecosystem, on markers of immune status, dyslipidemia, inflammation and oxidative stress alone or in combination with HAART (highly-active antiretroviral therapy).
Timeline
- Start
- 2006-05
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ProAlgaZyme | Other / unclassified | — | — |